Michèle Fonfrède

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnès Hartemann, G. Bensimon, Christine Payan et al. · The Lancet Diabetes & Endocrinology · 2013 · 422 citations

Medicine, Immunology, Pharmacotherapy +10

Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes

Carole E. Aubert, Pablo Michel, Philippe Gillery et al. · Diabetes/Metabolism Research and Reviews · 2014 · 58 citations

Medicine, Endocrinology, Internal Medicine +14

Multicenter Evaluation of Tosoh Glycohemoglobin Analyzer

I Gibb, Angela Parnham, Michèle Fonfrède et al. · Clinical Chemistry · 1999 · 54 citations · Full text

Pharmacy, Biochemistry, Hematology +15

Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage

Paola Sanchez-Peña, Aurélien Nouet, Frédéric Clarençon et al. · Critical Care Medicine · 2011 · 33 citations

Medicine, Neurology, Surgery +17

High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A–MODY and familial young-onset type 2 diabetes: A grey zone analysis

Christine Bellanné‐Chantelot, Jöel Coste, Cécile Ciangura et al. · Diabetes & Metabolism · 2015 · 26 citations

Medicine, Clinical Sciences, Diabetology +6